CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 198 filers reported holding CHEMOCENTRYX INC in Q2 2020. The put-call ratio across all filers is 0.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $13,877,000 | -3.4% | 253,230 | -29.1% | 1.25% | -16.8% |
| Q1 2020 | $14,359,000 | +559.6% | 357,379 | -26.1% | 1.50% | +60.4% |
| Q3 2014 | $2,177,000 | +31.5% | 483,741 | +93.7% | 0.94% | +8.1% |
| Q1 2014 | $1,656,000 | -71.4% | 249,700 | -75.0% | 0.86% | -78.8% |
| Q4 2013 | $5,790,000 | – | 1,000,000 | – | 4.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |